SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001156175-14-000010
Filing Date
2014-02-12
Accepted
2014-02-12 17:28:58
Documents
1
Group Members
BROOKSIDE CAPITAL PARTNERS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 BROOKSIDE SC13G FOR PORTOLA PHARMACEUTICALS, INC. AS OF DECEMBER 31, 2013 Portola13G.txt SC 13G/A 7583
  Complete submission text file 0001156175-14-000010.txt   9158
Mailing Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116
Business Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BROOKSIDE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001156175 (see all company filings)

IRS No.: 043517087 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Subject) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87472 | Film No.: 14601597
SIC: 2834 Pharmaceutical Preparations